Cannabis News
Authoritative coverage of the global cannabis industry — regulation, investment, markets and policy, reported for the people who run it.
Cannabis News · page 175
- Uncategorized
Deutscher Cannabisplan ‘legal’, Luxemburgische Cannabisanfrage, Ungarn wegen Cannabisverstoßes auf der Anklagebank, Ex-irischer Premierminister unterstützt Entkriminalisierung u.a….
Zwei führende deutsche Strafrechtler sind der Meinung, dass die Bemühungen des Landes um eine Legalisierung des Drogenkonsums für Erwachsene im Rahmen eines Menschenrechtsmandats vorangetrieben werden können, das mit dem europäischen und internationalen Recht vereinbar ist.
- Adult-Use
German Cannabis Plan ‘Legal’, Luxembourg Cannabis Query, Hungary In Dock For Cannabis Breach, Ex-Irish PM Backs Decriminalisation et al…
TWO leading German criminal lawyers believe the country’s efforts to introduce adult-use legalisation can progress under a Human Rights remit which will comply with European and international law.
- Policy & Regulation
High & Dry: Banking crisis to further choke funding for cannabis sector
Cannabis Daily News BANKING High & Dry: Banking crisis to further choke funding for cannabis sector The global banking turmoil threatens to squeeze U.S. cannabis companies already struggling with meager funding sources by drying up support from regional lenders and tightening fundraising from alternative avenues, reports Market Screener.
- Uncategorized
Business of Cannabis NYC Sessions: New York Will ‘Become The Most Sustainable, Equitable, and Demographically Diverse Market In The Industry’
Business of Cannabis’ third New York Sessions event took place last month (February 23), bringing together some of the leading voices in the state at a crucial juncture for its cannabis industry. 5 Key Takeaways New York is expected to become the second largest cannabis market in the US, behind only California, by 2033.
- Medical
Cantourage UK and CannFX make history by delivering the first ever Medical Cannabis Flower from New Zealand to the UK
CannFx’s dried flowers are the first New Zealand medical cannabis products to be made available in the United Kingdom CannFx’s indoor facility will continue to release more high-quality cultivars coming out of the agricultural epicentre of Australasia over the next few months CannFx’s medical products are the latest addition to the offering of Cantourage UK’s…
- Hemp Industry
Bipartisan senators file bill to ease restrictions on industrial hemp farmers
INDUSTRIAL HEMP ACT Bipartisan senators file bill to ease restrictions on industrial hemp farmers A bipartisan pair of U.S. senators have filed a bill to reduce regulations on farmers that grow industrial hemp for non-extraction purposes, reports Marijuana Moment.
- Policy & Regulation
UK Government’s Refusal To Publish Drug Decriminalisation Report ‘Further Evidence’ Of Them Ignoring ACMD and Evidence-Based Policy
A report from the government’s Advisory Council on the Misuse of Drugs (ACMD) that recommended the decriminalisation of drugs will remain the only one in the council’s history not to be released to the public.
- Cultivation
Benefits of F1 Cannabis Hybrids from Royal Queen Seeds
F1 hybrids have revolutionised the way we grow and use plants.
- Companies
Another Canadian cannabis producer pauses production over ‘edibles’ dispute with Health Canada
INDIVA LIMITED Another Canadian cannabis producer pauses production over ‘edibles’ dispute with Health Canada Indiva Limited has halted production of some of its products due to a disagreement with Health Canada over the classification of its cannabis lozenges, reports MJBiz.
- Press releases
MGC Pharmaceuticals Has Completed The Pre-Clinical Study On CimetrA™, Exploring The Mechanism Of Action (MoA) Of The Product
PRESS RELEASE FURTHER to the announcement dated 16 January 2023, Celadon Pharmaceuticals Plc (AIM: CEL), a UK-based pharmaceutical company focused on the research, cultivation, manufacturing and sale of breakthrough cannabis-based medicines, announces that its current Home Office licence has been successfully updated to allow the commercial sale of its high Δ9-tetrahydrocannabinol (“THC”) product, following the Company’s…
- Uncategorized
Vorgeschlagene Änderungen des deutschen Rahmens für medizinisches Cannabis würden “ernsthafte Auswirkungen auf Patienten und Industrie” haben, wenn sie morgen in Kraft treten
Es wird erwartet, dass der Gemeinsame Bundesausschuss (G-BA) morgen wichtige Änderungen an den Rahmenbedingungen für medizinisches Cannabis in Deutschland bekannt geben wird.
- Medical
Proposed Changes To Germany’s Medical Cannabis Framework Would ‘Seriously Impact Both Patients And Industry’ If Brought In Tomorrow
TOMORROW, Germany’s Federal Joint Committee (G-BA) is expected to announce major changes to the country’s medical cannabis framework.
